BetterScholar BetterScholar

J. Kort

Hepatology, Journal of Immunology, Lancet. Infectious Diseases, Journal of Hepatology, New England Journal of Medicine, Clinical Gastroenterology and Hepatology, Gastroenterology Show more
11
Role
Title
Level Year L/R
🐜 Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
19 auth. X. Forns, Samuel S. Lee, J. Valdes, S. Lens, R. Ghalib, H. Aguilar, F. Felizarta, T. Hassanein, H. Hinrichsen, D. Rincón, ... R. Morillas, S. Zeuzem, Y. Horsmans, D. Nelson, Yao Yu, Preethi Krishnan, Chih‐Wei Lin, J. Kort, F. Mensa 		9 2017
9
🐜
🐜 Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.
22 auth. P. Kwo, F. Poordad, A. Asatryan, Stanley Wang, D. Wyles, T. Hassanein, F. Felizarta, M. Sulkowski, E. Gane, B. Maliakkal, ... J. S. Overcash, S. Gordon, A. Muir, H. Aguilar, K. Agarwal, G. Dore, Chih‐Wei Lin, Ran Liu, Sandra S. Lovell, T. Ng, J. Kort, F. Mensa 		8 2017
8
🐜
🐜 Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
38 auth. S. Zeuzem, G. Foster, Stanley Wang, A. Asatryan, E. Gane, J. Feld, T. Asselah, M. Bourliere, P. Ruane, H. Wedemeyer, S. Pol, R. Flisiak, F. Poordad, W. Chuang, C. Stedman, ... S. Flamm, P. Kwo, G. Dore, Gladys Sepúlveda-Arzola, S. Roberts, R. Soto‐malave, K. Kaita, M. Puoti, J. Vierling, E. Tam, H. Vargas, R. Bruck, F. Fuster, S. Paik, F. Felizarta, J. Kort, B. Fu, Ran Liu, T. Ng, T. Pilot-matias, Chih‐Wei Lin, R. Trinh, F. Mensa 		8 2018
8
🐜
🐜 Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
22 auth. T. Asselah, K. Kowdley, Neddie Zadeikis, Stanley Wang, T. Hassanein, Y. Horsmans, M. Colombo, F. Calinas, H. Aguilar, V. de Lédinghen, ... P. Mantry, C. Hézode, R. Marinho, K. Agarwal, F. Nevens, M. Elkhashab, J. Kort, Ran Liu, T. Ng, Preethi Krishnan, Chih‐Wei Lin, F. Mensa 		8 2017
8
🐜
🐜 Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
18 auth. D. Wyles, F. Poordad, Stanley Wang, L. Alric, F. Felizarta, P. Kwo, B. Maliakkal, K. Agarwal, T. Hassanein, F. Weilert, ... Samuel S. Lee, J. Kort, Sandra S. Lovell, Ran Liu, Chih‐Wei Lin, T. Pilot-matias, Preethi Krishnan, F. Mensa 		7 2018
7
🐜
🐜 Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment
16 auth. F. Poordad, F. Felizarta, A. Asatryan, M. Sulkowski, R. Reindollar, C. Landis, S. Gordon, S. Flamm, M. Fried, D. Bernstein, ... Chih‐Wei Lin, Ran Liu, Sandra S. Lovell, T. Ng, J. Kort, F. Mensa 		7 2017
7
🐜
🐜 Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure
20 auth. F. Poordad, S. Pol, A. Asatryan, M. Buti, D. Shaw, C. Hézode, F. Felizarta, R. Reindollar, S. Gordon, S. Pianko, ... M. Fried, D. Bernstein, J. Gallant, Chih‐Wei Lin, Y. Lei, T. Ng, Preethi Krishnan, Sarah A. Kopecky-Bromberg, J. Kort, F. Mensa 		7 2018
7
🐜
🐬 In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System
C. Denkinger, M. Denkinger, J. Kort, C. Metz, T. Forsthuber 		6 2003
6
🐬
🐜 ENDURANCE-3: safety and efficacy of glecaprevir/pibrentasvir compared to sofosbuvir plus daclatasvir in treatment-naïve HCV genotype 3-infected patients without cirrhosis
18 auth. G. Foster, E. Gane, A. Asatryan, T. Asselah, P. Ruane, S. Pol, F. Poordad, C. Stedman, G. Dore, S. Roberts, ... K. Kaita, J. Vierling, H. Vargas, J. Kort, Chih‐Wei Lin, Ran Liu, T. Ng, F. Mensa 		6 2017
6
🐜
🐜 High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
15 auth. E. Gane, F. Poordad, Stanley Wang, A. Asatryan, P. Kwo, J. Lalezari, D. Wyles, T. Hassanein, H. Aguilar, B. Maliakkal, ... Ran Liu, Chih‐Wei Lin, T. Ng, J. Kort, F. Mensa 		6 2016
6
🐜
🐜 T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells1
10 auth. T. Forsthuber, C. Shive, W. Wienhold, K. D. de Graaf, E. Spack, R. Sublett, ... A. Melms, J. Kort, M. Racke, Robert Weissert 		6 2001
6
🐜